First‐trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population
- 1 March 2002
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 19 (3) , 240-242
- https://doi.org/10.1046/j.1469-0705.2002.00655.x
Abstract
To compare first-trimester placental volume in chromosomally abnormal and normal pregnancies. Placental volumes were routinely recorded at the time of nuchal translucency thickness measurement at 10–13 weeks of gestation. This was done using customized three-dimensional ultrasound equipment and measurements were then converted to the placental quotient (placental volume/fetal crown–rump length). The possible difference in placental quotient between chromosomally normal and abnormal pregnancies was examined. A total of 2863 pregnancies was evaluated, including 17 with major chromosomal defects (nine cases of trisomy 21, four of trisomy 18, two of trisomy 13, and one each of Turner syndrome and 48,XXY + 21). The median placental quotient in the chromosomally abnormal group (0.67) was significantly lower than that in the normal fetuses (0.98). In nine of the 17 affected pregnancies the quotient was below the 10th centile of the normal range. Assessment of placental volume may prove to be useful in first-trimester risk assessment for chromosomal anomalies. Copyright © 2002 ISUOGKeywords
This publication has 8 references indexed in Scilit:
- Three-dimensional Ultrasound Measurement of the Placental Volume in Early Pregnancy: Method and Correlation with Biochemical Placenta ParametersPlacenta, 2001
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Second‐trimester measurements of placental volume by three‐dimensional ultrasound to predict small‐for‐gestational‐age infantsUltrasound in Obstetrics & Gynecology, 1998
- Results of routine fetal nuchal translucency measurement at weeks 10–13 in 4233 unselected pregnant womenPrenatal Diagnosis, 1998
- Increased Nuchal Translucency as a Marker for Fetal Chromosomal DefectsNew England Journal of Medicine, 1997
- Serum screening for Down's syndrome between 8 and 14 weeks of pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992